Mesoblast
MESO
69 hedge funds and large institutions have $50.5M invested in Mesoblast in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 13 closing their positions.
755% more call options, than puts
Call options by funds: $24.8M | Put options by funds: $2.9M
56% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 16
0.72% less ownership
Funds ownership: 3.27% → 2.55% (-0.72%)
7% less funds holding
Funds holding: 74 → 69 (-5)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
33% less capital invested
Capital invested by funds: $75.7M → $50.5M (-$25.1M)
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.43M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$1.4M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$999K |
| 4 |
MGP
M&G plc
London,
United Kingdom
|
+$984K |
| 5 |
HF
HRT Financial
New York
|
+$570K |
Top Sellers
| 1 |
Legal & General Group
London,
United Kingdom
|
-$12.2M |
| 2 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
-$2.37M |
| 3 |
Morgan Stanley
New York
|
-$1.37M |
| 4 |
Jane Street
New York
|
-$1.14M |
| 5 |
BlackRock
New York
|
-$758K |
MESO Hedge Fund Activity: Q1 2026 in Review
69 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2026, worth a combined $50.5M — down 33% from $75.7M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of MESO and 10 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 25 added.
The largest buyer was Bank of America, adding an estimated $1.43M. The largest seller was Legal & General Group, exiting entirely with an estimated $12.2M sold.
- 69 institutional investors held Mesoblast (MESO) as of Q1 2026, down from 74 in Q4 2025.
- Funds reported $50.5M of Mesoblast stock for Q1 2026, down 33% quarter-over-quarter.
- 10 funds opened new Mesoblast positions in Q1 2026 and 13 closed out, a net change of -3 holders.
- The largest Mesoblast buyer in Q1 2026 was Bank of America, an estimated $1.43M added.
- The largest Mesoblast seller in Q1 2026 was Legal & General Group, an estimated $12.2M sold.
Based on aggregated 13F filings for Q1 2026.